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Abstract
Introduction: Stress cardiomyopathy is a condition of chest pain, breathlessness, abnormal heart
rhythms and sometimes congestive heart failure or shock precipitated by intense mental or physical
stress.
Case presentation: A 64-year-old male with a known diagnosis of moderate-to-severe aortic
stenosis and advised that valve replacement was not urgent, presented with acute pulmonary
edema following extraordinary mental distress. The patient was misdiagnosed as having a "massive
heart attack" and died when managed by a traditional protocol for acute myocardial infarction/
coronary artery disease, irrespective of his known aortic stenosis.
Conclusion:  Intense mental stress poses a considerable risk, particularly to patients with
significant aortic stenosis. As described here, it can precipitate acute pulmonary edema.
Importantly, effective management of acute pulmonary edema due to stress cardiomyopathy in
patients with known aortic stenosis requires its distinction from acute pulmonary edema caused by
an acute myocardial infarction. Treatment options include primarily urgent rhythm and/or rate
control, as well as cautious vasodilation.
Introduction
Stress cardiomyopathy or "myocardial stunning" is a con-
dition precipitated by severe physical or emotional stress
which was first identified in the 1990s [1]. After an emo-
tional trauma, such as the death of a child or spouse, 10-
30 times normal plasma levels of epinephrine, norepine-
phrine and dopamine, which remained high for several
days, have been documented. This toxic increase in circu-
lating catecholamines is thought to "stun" the heart and
prevent it from pumping properly [2]. The result is a dan-
gerous reduction in blood flow, chest pain, breathless-
ness, arrhythmias, and sometimes congestive heart failure
or shock. In distinction to an acute myocardial infarction,
stress cardiomyopathy per se is generally transient with-
out long-term damage to the heart.
Aortic stenosis (AS) is the most common valvular heart
disease [3]. It affects 2-3% of older North Americans and
Europeans. The severity of the disease can be difficult to
diagnose. It is not known whether exercise testing of
asymptomatic patients with severe AS can reliably identify
patients most vulnerable to mental stress. In the case
reported, the AS was borderline moderate-to-severe and,
in the cardiologist's opinion, had not reached a critical
stage requiring urgent aortic valve replacement (AVR). Yet,
the patient developed acute pulmonary edema in the
aftermath of extraordinary distress. Although the current
report seems to be the first describing this medical emer-
gency, acute pulmonary edema precipitated by mental
stress in patients with AS may not be that rare.
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Case presentation
The case involves a 64-year-old male scientist with a diag-
nosis of moderate-to-severe aortic stenosis (AS) and mild-
to-moderate aortic regurgitation, but no signs and symp-
toms of congestive heart failure, and no history of myocar-
dial infarction (MI), or coronary artery disease (CAD).
The patient had normal blood pressure and was taking no
medications. His AS was monitored by serial echocardio-
grams (Doppler and two-dimensional), the last of which
showed a mean transvalvular gradient of 40 mm Hg and
a LV end-systolic dimension of 47 mm. The last cardiol-
ogy evaluation noted that the patient was fairly active but
"may be beginning to get mildly symptomatic." He started
to notice chest pressure during certain exertion which was
promptly relieved by rest and "could be angina." The
patient was told that he should not go jogging, that he was
near the point where he should consider AVR, but that the
AVR "was not urgent". Two months later, the patient
became very distressed and angry seeing a family member
hurt by outrageous, unlawful conduct. Within about one
hour of this stressful event, while engaging in a sedentary
activity, he suddenly experienced severe shortness of
breath and began to cough up frothy pink sputum. First
responders and emergency physicians were informed that
the patient had AS and was just extremely upset. In the
ambulance, the patient received oxygen, morphine sulfate
(10 mg), furosemide (100 mg) and sublingual nitroglyc-
erin. On presentation in the emergency department (ED)
about two hours after the extraordinary mental distress
began, the patient was alert, had chest rales, a pulse of 123
beats/min, a blood pressure of 121/73 mm Hg, and a res-
piratory rate of 28-32. His chest X-ray indicated pulmo-
nary edema. During the first 25 minutes in the ED, as he
received more nitroglycerin (as paste twice to the chest),
another 2 mg morphine sulfate, 2 mg midazolam, and
was intubated for ventilation, vigorous diuresis occurred
and the patient's initially normal blood pressure plum-
meted to <70 mm Hg, systolic. At that point, the ECG also
showed that the patient had developed atrial fibrillation
(AF) with a rapid ventricular rate of 124 beats/min. The
patient was started on i.v. dopamine (10 ug/kg/min
through most of the next hour). His heart rate increased
to148 beats/min, and blood pressure rose to 80-100 mm
Hg but then fell again. Several attempts of cardioversion
with shocks of 100, 200 and 300 joules, respectively, (7.5
mg valium i.v. for sedation) were begun only 40 minutes
after AF was identified, and the patient's condition had
worsened considerably. Subsequent administration of
digoxin (0.25 mg i.v.) and procainamide (1 g i.v. over 20
min) slowed the ventricular rate to 125 beats/min and
raised the blood pressure only briefly to 96/62 mm Hg.
Cardioversion attempts (1 × 300 J and 3 × 360 J after 2 ×
2.5 mg i.v. additional valium) were continued, but the
patient remained in AF with ventricular tachycardia of
120 beats/min and worsening hypotension (BP, 36/30
mm Hg). After a fourth 360 J shock no palpable pulse was
noted. After 25 min of CPR including four ampoules of
epinephrine, each followed by a further shock of 360 J,
which resulted in no rhythm, ventricular fibrillation and
agonal rhythm, all resuscitation attempts were termi-
nated. The medical chart summary was that the patient
had died from a massive AMI. Yet, cardiac enzymes were
negative and the autopsy confirmed aortic stenosis as the
cause of death with a bicuspid, heavily calcified aortic
valve, left ventricular hypertrophy and moderate dilation,
focal pulmonary hemorrhages, primarily mild CAD, no
evidence of a recent MI, nor any other major abnormali-
ties.
Discussion
The very sudden onset of severe dyspnea and cough pro-
ducing frothy pink sputum about one hour after the
patient became extremely upset, as well as all the evidence
from his clinical evaluations before and shortly thereafter,
strongly indicate that the acute pulmonary edema was
precipitated by the preceding emotional trauma and the
result of stress cardiomyopathy. Normal cardiac enzymes
and the autopsy findings ruled out any AMI.
Irrespective of the patient's known preexisting AS, he was
managed primarily with oxygen therapy, morphine sul-
fate, large doses of both diuretic and nitrates, followed by
inotropes. Unfortunately, most of these conventional
interventions were not appropriate or beneficial. Current
evidence does not support morphine in the treatment of
acute pulmonary edema/acute decompensated heart fail-
ure [4]. Large doses of nitrites, such as, nitroglycerin paste
which can't be properly titrated, should be avoided in
advanced AS. Excessive furosemide caused vigorous diure-
sis potentially contributing to the subsequent precipitous
blood pressure fall and intractable hypotension. Individ-
uals who present with a very acute heart failure tend to
have it primarily due to a sudden pressure overload caus-
ing an abnormal fluid distribution (into lungs), rather
than a real volume overload. Aggressive volume depletion
leading to hypovolemia can exacerbate a rapid heart rate
and promote the development of AF, conditions which in
AS almost certainly precipitate hypotension.
Another concern is that electrical cardioversion was
delayed for some 40 minutes after AF was positively iden-
tified, and medical rhythm/rate control even longer while
the patient's condition steadily deteriorated. Prolonged
infusion of dopamine, started when the patient became
hypotensive, would not be expected to improve his hemo-
dynamic condition. The thickened left ventricle (LV) in
AS, which has a low or diminished contractile reserve, can
hardly be pushed by inotropes to contract more forcefully,
while both the subendocardial perfusion (due to the ven-
tricular tachycardia) and the LV filling pressure (due toCases Journal 2009, 2:9128 http://www.casesjournal.com/content/2/1/9128
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prior excessive diuresis and AF) are substantially inade-
quate. Moreover, when an emotional trauma precipitated
the congestive heart failure by flooding the system with
catecholamines, the high levels of endogenous epine-
phrine, norepinephrine and dopamine have been shown
to persist for many hours. Thus, more dopamine (with
actions that also partially overlap those of epinephrine
and norepinephrine), may amplify (not correct) the pre-
cipitating factors and exacerbate the heart failure.
According to the general ACC/AHA Guidelines for the
Management of Valvular Heart Disease, the cornerstones
in the management of acute pulmonary edema in patients
with underlying AS should be urgent rhythm and rate con-
trol, and vasodilation for decongestion of the lungs [3].
However, when it comes to stress cardiomyopathy and
specific interventions to improve symptoms and stabilize
such patients for AVR, challenging medical issues remain
to be fully resolved. Potential treatment options to con-
sider include the following.
1. In a patient with known AS, paramedics should start
respiratory support, but only cautiously administer nitro-
glycerine, diuretic and, for high blood pressure, angi-
otensin converting enzyme (ACE) inhibitors.
2. If the pulmonary edema is associated with recent onset
AF, or AF develops in the ED, prompt electrical cardiover-
sion to restore normal sinus rhythm and slow the ven-
tricular rate is mandatory. Both AF and a rapid ventricular
rate have especially adverse effects in patients with AS. AF
can drastically reduce the pre-load, depress pump func-
tion and worsen the acute heart failure, since the filling of
the hypertrophic LV is up to 40% dependent on proper
atrial contractions. Concurrently, AF increases the left
atrial and pulmonary venous pressure which exacerbates
the pulmonary edema.
3. If the pulmonary edema is associated with severe tach-
ycardia (or AF and electrical cardioversion failed), phar-
macologic rate (and rhythm) control is essential in AS.
Tachycardia and shorter diastolic perfusion time can cause
sustained subendocardial ischemia in a hypertrophied
heart with reduced coronary blood flow and limited coro-
nary vasodilator reserve. Subendocardial ischemia in turn
can trigger arrhythmias, lead to LV diastolic failure and
compromise systolic function. An optimal strategy for the
medical control of rapid ventricular rates due to metal
stress in AS patients has yet to be defined, but drugs to
consider may include the following:
(a) There is a rationale for cautious use of intravenous,
short-acting beta-adrenergic blocking agents, such as
esmolol and landiolol, if excessive adrenergic stimulation
related to mental stress is the suspected mechanism for
the tachycardia or tachyarrhythmia.
Esmolol, an ultra short-acting (plasma half life: 9 min-
utes) and relatively cardioselective beta blocker, has been
shown (at 25-300 ug/kg/min) to rapidly slow the heart
rate in patients with AF, to effectively relieve chest pain
due to acute myocardial ischemia, and to achieve a clini-
cal significant reduction in heart rate (20% or <100 beats
per minute) in about 70% of patients, and a conversion to
sinus rhythm in about 15%. The principle adverse effect of
esmolol is hypotension due to a decrease in cardiac out-
put. But even tachyarrhythmias associated with congestive
heart failure, where beta blockers are otherwise contrain-
dicated, may be relatively safely managed with esmolol by
starting with a small dose, slowly increasing it while the
patient is closely monitored, and decreasing/discontinu-
ing the infusion when complications arise which tends to
reverse them [5,6]
Landiolol, a short acting selective beta-1 adrenergic
blocker, has been reported to effectively control tachycar-
dia in patients during surgery including one patient with
severe aortic stenosis and, in one case, to convert AF to
sinus rhythm [7,8]. Beta-blockers with vasodilating
effects, such as celiprolol may have the advantage of
decreasing the cardiac index the least [9].
(b) Amiodarone (single bolus or short term infusion)
effectively treats many cardiac arrhythmias and may be an
option for fast heart rate control when other measures fail
[10-12]. Although AS patients have generally been
excluded from these studies, amiodarone rapidly slowed
the ventricular rate and restored normal sinus rhythm in
32% of patients with advanced congestive heart failure,
including pulmonary edema and AF. In critically ill
patients, who developed AF with a rapid ventricular
response and associated fall in systolic blood pressure,
amiodarone rapidly and significantly reduced the heart
rate with beneficial changes in blood pressure and cardiac
output. It has been used in combination with carvedilol
(beta1-, beta2-, alpha1-blocker) for rapid reduction of the
heart rate in acute AF and severe heart failure [13].
4. For decongestion of the lungs in patients with AS,
vasodilators should be preferentially used over diuretics
to maintain a sufficiently elevated left ventricular filling
pressure and produce an adequate forward stroke volume
and cardiac output. Vasodilation with intravenous nitro-
prusside has been reported to rapidly and significantly
increase the cardiac index in critically ill patients with
severe AS and congestive heart failure as long as they are
not hypotensive [3,14] Particularly, when mental stress
and high levels of catecholamines caused vasoconstrictionPublish with BioMed Central    and   every 
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in the coronary and peripheral circulation with a propor-
tional increase in the effective after-load, then nitroprus-
side may be expected to improve cardiac output by
reducing the systemic vascular resistance and correcting
the after-load mismatch. To optimize therapy, the nitro-
prusside must be guided by invasive monitoring and care-
fully titrated to produce a mean arterial pressure of 60-70
mm Hg.
Administration of both a short acting beta blocker and
nitroprusside in combination rather than sequentially
may be more effective, if the acute pulmonary edema
coexists with acute AF, given the interaction between the
two.
Conclusion
This case illustrates that extraordinary psychological stress
can precipitate acute pulmonary edema in patients with
advanced AS and, like physical exertion, poses a signifi-
cant risk to them. These patients and their families need to
be warned of this risk to avoid it as much as possible. The
differentiation between stress cardiomyopathy and AMI-
caused acute pulmonary edema is critically important in
patients with known AS for effective emergency care to
alleviate symptoms and stabilize them for AVR. Potential
treatment options for acute pulmonary edema due to
stress cardiomyopathy in such patients include urgent
electrical cardioversion, intravenous, short acting beta
blockers, or amiodarone for rhythm and/or rate control,
as well as cautious vasodilation with intravenous nitro-
prusside, invasively monitored to decongest the lungs and
improve LV performance. By contrast, aggressive diuresis
and preload reduction must be avoided to prevent intrac-
table hypotension and hypoperfusion. Inotropes like
dopamine are not indicated after emotional stress and cat-
echolamine surge.
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